Celanese Corporation

Celanese Corporation agreed to sell an additional 19% of the Nutrinova food-ingredients joint venture to Mitsui & Co., Ltd. for approximately $152 million in cash, a deal expected to close in the fourth quarter subject to customary conditions. The sale will cut Celanese's retained interest in Nutrinova from 30% to 11%, and the interest being sold generated roughly $4 million of equity earnings in 2025, meaning the consideration equals about 38 times that contribution. Proceeds will reduce debt, fund upcoming maturities, and count toward Celanese's goal of generating $1 billion from divestitures by the end of 2027; combined with the completed $500 million Micromax divestiture, the two announced deals total approximately $652 million, about 65% of that objective. Celanese ended 2025 with approximately $11.3 billion of company-defined non-GAAP net debt and targets about $10 billion by the end of 2026 and below $9 billion by the end of 2027, while aiming for $700 million to $800 million of company-defined non-GAAP free cash flow in 2026. Under the related diketene-facility arrangement, Nutrinova will cover the facility's full purchase price and ongoing operating costs, leaving Celanese with no funding obligation.

Celanese Corporation has agreed to sell an additional 19% stake in its Nutrinova food ingredients joint venture to Mitsui & Co., Ltd. for $152 million in cash, reducing its ownership to 11% while strengthening its balance sheet. The transaction, which contributed about $4 million in equity earnings in 2025, will allow Celanese to continue participating in the food ingredients business. Proceeds will be used to reduce net debt and repay upcoming maturities, supporting its goal of $1 billion in divestiture proceeds by the end of 2027. As part of the deal, Celanese will temporarily operate a diketene production facility in Frankfurt before transferring it to Nutrinova, with Mitsui covering the purchase price and operating costs. The transaction is subject to customary closing conditions.

Celanese Corporation and VIGOR Precision Ltd. have signed a strategic partnership agreement to develop and commercialize lightweight plastic joint solutions for humanoid robots. Under the agreement, Celanese will supply VIGOR with targeted high-performance plastic materials and technical support, aiming to reduce joint module weight by more than 30 percent by replacing traditional metals. The partnership focuses on overcoming technical challenges in high strength, temperature resistance, precision transmission, and dimensional accuracy. VIGOR CEO Hoi-sang Chan and Celanese Senior Vice President Todd Elliott attended the signing ceremony at Celanese's Shanghai Commercial and Technology Center.

Celanese reported that the Amsterdam District Court dismissed damages claims in a major legal dispute, removing a significant legal overhang. The ruling dismissed claims brought by Shell Chemicals Europe B.V. and parties represented by Stichting Ethylene Claims, eliminating potential financial liability linked to a high-profile European Commission settlement. The decision simplifies the risk picture for Celanese, which recently reported Q2 2026 sales of US$2,752 million and net income of US$125 million, compared with US$2,532 million and US$197 million a year earlier. The stock closed at US$43.89 and has seen pronounced volatility, with the share price down over 60% across the past three years and over 70% across five years.

Celanese Corp. reported a drop in second-quarter profit. Net earnings fell to $125 million, or $1.13 per share, from $197 million, or $1.80 per share, a year earlier. Adjusted earnings rose to $2.45 per share from $1.43 per share last year. Net sales increased to $2.75 billion from $2.53 billion, reflecting a 4% increase in volume and a 14% increase in price. For the third quarter, Celanese expects adjusted earnings of $1.35 to $1.75 per share, and it continues to expect full-year adjusted earnings of about $6.00 per share.

The Amsterdam District Court has dismissed in their entirety the damages claim brought by Shell Chemicals Europe and a declaratory judgment claim from certain Repsol entities against Celanese and its co-defendants. Both claims arose from follow-on litigation related to a 2020 settlement with the European Commission over past ethylene purchases in North-Western Europe. Celanese stated that the decisions confirm its position that the claimants are not entitled to recover damages and that it will continue to defend against remaining claims in Dutch and German courts.

Celanese Corporation declared a quarterly cash dividend of $0.03 per share on its common stock. The dividend is payable on August 10, 2026, to stockholders of record as of July 28, 2026. Celanese is a global chemical and specialty materials company with 2025 net sales of $9.5 billion.

Turtle Creek Asset Management highlighted Celanese Corporation as having a significant competitive edge due to its disproportionate use of low-cost U.S. natural gas in production, according to the firm's first-quarter 2026 investor letter. Celanese, a global specialty chemical and materials company, was the portfolio's largest detractor after reporting weaker-than-expected EBITDA and EPS, yet it continued to generate substantial free cash flow. Turtle Creek noted that higher global feedstock costs, such as natural gas, amplify Celanese's advantage. The stock closed at $51.23 on June 17, 2026, with a market capitalization of $5.62 billion, and 49 hedge funds held the name at quarter-end, up from 42 in the prior quarter.

Celanese Corporation has partnered with Siegwerk to increase the supply of sustainable solutions in the printing ink value chain. The collaboration uses Celanese's bio-based ethyl acetate, which contains 50% renewable content, as a drop-in solution in Siegwerk's existing ink formulations to support its SustainUP program under the HorizonNOW 2030 sustainability strategy. The partnership aims to reduce environmental impact while maintaining performance standards and advancing circular solutions in a practical and scalable way. Celanese shares have lost 4.5% over the past year against the industry's 8.7% growth.